Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 866 entries
View as:

A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01853306 Org: User:
Start: 03/18/13 End: 06/29/17 Due: 06/29/18

A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT02629159 Org: User:
Start: 12/01/15 End: 09/30/27 Due: 09/30/28

An Observational Study to Assess Next Generation Emulsion Preservative Free Eye Drops (NGE-UD) on Dry Eye Symptoms and Quality of Life of Adult Participants With Mild to Moderate Dry Eye Disease (DED)

Phase: N/A Priority: Normal
NCT ID: NCT06443775 Org: User:
Start: 06/17/24 End: 10/14/24 Due: 10/14/25

A Study to Evaluate the Bioavailability of Risankizumab Following Subcutaneous Dosing in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT05283694 Org: User:
Start: 09/11/17 End: 06/12/18 Due: 06/12/19

BI 655066/ABBV-066/Risankizumab Compared to Placebo in Patients With Active Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02719171 Org: User:
Start: 04/30/16 End: 08/31/17 Due: 08/31/18

A Study to Asses Effectiveness and Treatment Management of Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in Adult Participants Ineligible for Intensive Chemotherapy With de Novo Acute Myeloid Leukemia (AML) in Italy

Phase: N/A Priority: Normal
NCT ID: NCT06058741 Org: User:
Start: 03/04/24 End: 11/30/26 Due: 11/30/27

Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in China

Phase: N/A Priority: Normal
NCT ID: NCT05144243 Org: User:
Start: 01/06/22 End: 04/30/25 Due: 04/30/26

An Open-Label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62% Applied to the Upper Arms and Shoulders and Use of a T-shirt Barrier

Phase: N/A Priority: Normal
NCT ID: NCT01130298 Org: User:
Start: 05/31/10 End: 05/31/10 Due: 05/31/11

A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

Phase: N/A Priority: Normal
NCT ID: NCT06953960 Org: User:
Start: 06/09/25 End: 12/31/30 Due: 12/31/31

Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury

Phase: N/A Priority: Normal
NCT ID: NCT04375397 Org: User:
Start: 06/06/20 End: 06/08/21 Due: 06/08/22

A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Phase: N/A Priority: Normal
NCT ID: NCT02819635 Org: User:
Start: 09/26/16 End: 12/13/21 Due: 12/13/22

A Study of Duvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT02640833 Org: User:
Start: 07/31/16 End: 02/28/21 Due: 02/28/22

A Study to Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT05081557 Org: User:
Start: 11/17/21 End: 10/15/26 Due: 10/15/27

Safety, Tolerability and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Healthy Asian and Caucasian Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02596217 Org: User:
Start: 08/31/15 End: 06/30/17 Due: 06/30/18

A Study to Evaluate Adverse Events and How the Drug Moves Through the Body From Subcutaneous (SC) and Intravenous (IV) Doses of ABBV-382 in Healthy Adult Chinese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06632938 Org: User:
Start: 10/08/24 End: 05/15/25 Due: 05/15/26

A Study of SC-006 and in Combination With ABBV-181 in Subjects With Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03035279 Org: User:
Start: 03/08/17 End: 03/28/19 Due: 03/28/20

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT03725007 Org: User:
Start: 06/24/19 End: 05/05/27 Due: 05/05/28

A Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT02141997 Org: User:
Start: 07/31/14 End: 11/30/15 Due: 11/30/16

Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets

Phase: N/A Priority: Normal
NCT ID: NCT04340115 Org: User:
Start: 04/24/20 End: 08/31/25 Due: 08/31/26

A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation

Phase: N/A Priority: Normal
NCT ID: NCT02988674 Org: User:
Start: 12/22/16 End: 10/16/19 Due: 10/16/20

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRĪ±) Expression

Phase: N/A Priority: Normal
NCT ID: NCT04209855 Org: User:
Start: 12/31/19 End: 08/22/24 Due: 08/22/25

A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State

Phase: N/A Priority: Normal
NCT ID: NCT04451772 Org: User:
Start: 07/27/20 End: 01/03/24 Due: 01/03/25

A Study to Evaluate Pregnancy Outcomes in Females Treated With Oral Elagolix Tablets and Capsules

Phase: N/A Priority: Normal
NCT ID: NCT04464187 Org: User:
Start: 01/06/22 End: 01/23/29 Due: 01/23/30

Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis PatientsĀ“ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01768858 Org: User:
Start: 02/05/13 End: 08/13/17 Due: 08/13/18

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1

Phase: N/A Priority: Normal
NCT ID: NCT04223804 Org: User:
Start: 01/30/20 End: 02/27/23 Due: 02/27/24